Pharmacokinetics of glucuronidation of propranolol following oral administration in humans
β Scribed by K. K. Midha; R. M. H. Roscoe; T. W. Wilson; J. K. Cooper; J. C. K. Loo; A. Ho-Ngoc; I. J. McGilveray
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 336 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0142-2782
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Pharmacokinetic and bioavailability parameters of propranolol were estimated in 10 healthy adult subjects after single oral doses of two commercial tablet formulations of propranolol hydrochloride (2 Γ 40 mg). Plasma concentrations of propranolol were determined by a highβperformance liquidβchromatographic (HPLC) assay. Peak plasma concentrations of propranolol glucuronide were 6Β·8 times those of the corresponding peak propranolol plasma concentrations. The mean resident time (MRT) of propranolol and of propranolol glucuronide was determined for each subject for both formulations. The MRT of the parent drug was found to be longer than the MRT of the glucuronide metabolite for each of the subjects examined. Statistical moment analysis indicated that this phenomenon is attributable to extensive presystemic glucuronidation of the parent drug.
π SIMILAR VOLUMES
The pharmacokinetics of morphine-6-glucuronide (M6G) after both intravenous dosing and nasal administration were studied in sheep. The nasal formulation consisted of M6G in combination with an absorption promoting delivery system in the form of chitosan. The mean half-life of M6G after intravenous a
The kinetic behaviour of bovine erythrocyte Cu-Zn SOD was investigated in Sprague Dawley male rats after subcutaneous and oral administrations of doses ranging from 0.5 to 20mgkg-I. Studies have been carried out with SOD and SOD encapsulated into liposomes containing or not containing ceramides. The
## Abstract Clindamycin is an antimicrobial agent metabolized by CYP3A4. Gender may influence the pharmacokinetics of drugs metabolized by this pathway, however, no information about differences in the pharmacokinetics of clindamycin in men and women is available. The purpose of this study was to e
The single-dose and steady state pharmacokinetics of butorphanol and its metabolites, hydroxybutorphanol (HO-B) and norbutorphanol (NOR-B), were studied in nine healthy male volunteers. Each subject received a single 1 mg dose of butorphanol on days 1 and 6, and a 1 mg dose every 6 h (q6h) on days 2